Clinical Trial Update: Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating the adverse events of oral ABBV-932 in adults with depressive episodes associated with Bipolar I…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Bipolar Ii Disorder

Drugs mentioned

• ABBV-932

Snippet

Sponsor: AbbVie | Conditions: Bipolar I or II Disorder | Phase 2 | Status: RECRUITING